SEC Form 4/A · accession 0001209191-19-010478
GYRE THERAPEUTICS, INC. · GYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Howard Levy
Officer — Chief Medical Officer
Period of report
Feb 11, 2019
Accepted (ET)
Feb 14, 2019 · 9:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 11,694 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On February 13, 2019, the reporting person filed a Form 4 which reported that following his purchase of 2,485 shares from the 2018 Employee Stock Purchase Plan, he directly owned 11,867 shares of common stock. As reported in this amendment, the reporting person directly owns 11,694 shares of common stock. A sale of 173 share was reported on a Form 4 dated November 16, 2018.